These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2633797)

  • 1. Thromboxane receptor antagonists and endotoxaemia.
    Mikhailidis DP; Whitworth NH; Barradas MA; Jeremy JY; Dandona P
    Eicosanoids; 1989; 2(1):59, 61-2. PubMed ID: 2633797
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane A2 and platelets as mediators of coronary arterial vasoconstriction in myocardial ischaemia.
    Schrör K
    Eur Heart J; 1990 Apr; 11 Suppl B():27-34. PubMed ID: 2194808
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits.
    Robertson DN; Smith GM
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():204-7. PubMed ID: 2959049
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cancer blood-borne metastasis and platelets].
    Tanaka K; Fukumoto S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets and thromboxane A2 in the pathogenesis of aging penile vascular changes and impotence.
    Bornman MS; Dormehl IC; Franz RC; Du Plessis DJ; Jacobs DJ
    Arch Androl; 1986; 17(3):233-4. PubMed ID: 3606277
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandins and platelet function.
    Chaikhouni A
    J S C Med Assoc; 1983 Jun; 79(6):332-6. PubMed ID: 6350704
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
    Semrad SD; Moore JN
    Res Vet Sci; 1987 Sep; 43(2):137-42. PubMed ID: 3317581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endotoxemia and phagocytic function in premature infants. II. Role of the blood platelets].
    Jirillo E; Jatta E; Monno R; Panaro A; Papadia I; Longo Papadia L
    G Batteriol Virol Immunol; 1977; 70(1-6):34-9. PubMed ID: 614144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane and prostacyclin: implications for function and disease of the vasculature.
    McGiff JC
    Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological properties of prostacyclin-thromboxane system.
    Blaskó G
    Ther Hung; 1984; 32(2):45-51. PubMed ID: 6443751
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood and surface factors of importance for vascular surgery.
    Swedenborg J
    Acta Chir Scand Suppl; 1985; 529():3-6. PubMed ID: 3914153
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet thromboxane A2 synthesizing capacity is enhanced by fasting but diminished by diabetes mellitus in the rat.
    Jeremy JY; Mikhailidis DP; Thompson CS; Barradas MA; Dandona P
    Diabetes Res; 1988 Aug; 8(4):177-81. PubMed ID: 3233878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-generated thromboxane A2 enhances norepinephrine release from adrenergic nerves.
    Trachte GJ; Stein E
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1139-45. PubMed ID: 2849661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
    Machado AP; Saavedra JA; Ribeiro C
    Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoplasm free calcium ions as a second messenger].
    Matsuno K; Katabami F; Matsumiya H
    Rinsho Byori; 1987 Sep; Spec No 73():25-37. PubMed ID: 3437533
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of physiological and pathophysiological effects of thromboxane A2.
    Ogletree ML
    Fed Proc; 1987 Jan; 46(1):133-8. PubMed ID: 2948837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of thromboxane antagonism on the transit time of platelets through the spleen.
    Peters AM; Lane IF; Sinclair M; Irwin JT; McCollum CN
    Thromb Haemost; 1985 Aug; 54(2):495-7. PubMed ID: 2934858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.